Oklo (OKLO) Stock: Top Execs Dump $21M in Shares Amid Cramer Criticism and Earnings Disappointment

On April 1, 2026, Oklo Inc., a nuclear energy startup, faced significant scrutiny as its top executives sold over $21 million in company shares through pre-scheduled trading arrangements. This move coincided with criticism from CNBC's Jim Cramer, who questioned the company's profitability and commercial viability, and a disappointing earnings report that fell short of market expectations.

Oklo's leadership team, including CEO Jacob DeWitte and COO Caroline Cochran, executed substantial stock sales totaling north of $21 million. DeWitte's selling spree dates back to January, with transactions executed at prices ranging from approximately $50 to $100 per share. The executives utilized Rule 10b5-1 trading plans, which are designed to demonstrate predetermined selling schedules rather than opportunistic timing. However, the magnitude and timing of these transactions have raised eyebrows among investors and market observers.

DeWitte liquidated shares at average prices spanning $48.41 to $51.20, generating proceeds of $10,069,852. Following these transactions, DeWitte maintains direct ownership of 691,533 Class A shares while controlling over 20 million additional shares through indirect holdings. Co-founder and Chief Operating Officer Caroline Cochran executed similar transactions, also totaling $10,069,852, with sale prices fluctuating between approximately $47.99 and $51.79 per share. Her remaining direct stake stands at 658,039 shares. Chief Financial Officer Richard Bealmear participated as well, selling 16,342 shares at $51.08 each for total proceeds of $834,749. His current direct holdings amount to 386,008 Class A shares.

The executives' stock sales occurred amid criticism from Jim Cramer, who expressed skepticism about Oklo's commercial viability. Cramer stated that the company has minimal near-term revenue potential, raising questions about its ability to generate profits and meet investor expectations. This sentiment was further amplified by Oklo's recent earnings report, which revealed a quarterly loss of $0.27 per share. This result was significantly worse than Wall Street's -$0.17 forecast, leading to further concerns about the company's financial health.

Despite remaining nominally bullish, Wall Street analysts have trimmed their price objectives for Oklo. The current consensus target stands at $84.30, reflecting the adjusted expectations following the earnings disappointment and executives' stock sales. The combination of Cramer's criticism and the company's underperformance has raised questions about the long-term viability of Oklo and its prospects for success in the nuclear energy sector.

Investors and market participants are closely watching Oklo's response to these challenges. As the company navigates these hurdles, it will be crucial for the leadership team to communicate effectively with the market and demonstrate a clear path forward to address concerns about profitability and commercial viability. The recent stock sales by executives have undoubtedly added to the scrutiny surrounding Oklo, and the company will need to deliver strong results and strategic clarity to regain investor confidence.